Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 2.   Cytotoxic Activity of Immunotoxin SS1P Is Modulated by TACE-Dependent Mesothelin Shedding
  2. Zhang, Y. J.; Chertov, O.; Zhang, J. L.; Hassan, R.; Pastan, I.
  3. Cancer Research. 2011, Sep; 71(17): 5915-5922.
  1. 3.   A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity
  2. Feng, Y.; Shen, J. Y.; Streaker, E. D.; Lockwood, M.; Zhu, Z. Y.; Low, P. S.; Dimitrov, D. S.
  3. Arthritis Research & Therapy. 2011, Apr 8; 13(2): 12.
  1. 4.   CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors
  2. Baatar, D.; Olkhanud, P.; Newton, D.; Sumitomo, K.; Biragyn, A.
  3. Journal of Immunology. 2007, Aug; 179(3): 1996-2004.
  1. 5.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 6.   Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin
  2. Madiraju, C.; Edler, M. C.; Hamel, E.; Raccor, B. S.; Balachandran, R.; Zhu, G. Y.; Giuliano, K. A.; Vogt, A.; Shin, Y. S.; Fournier, J. H.; Fukui, Y. H.; Bruckner, A. M.; Curran, D. P.; Day, B. W.
  3. Biochemistry. 2005, NOV 15; 44(45): 15053-15063.
  1. 7.   SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations
  2. Alley, M. C.; Hollingshead, M. G.; Pacula-Cox, C. M.; W, W. R.; Hartley, J. A.; Howard, P. W.; Gregson, S. J.; Thurston, D. E.; Sausville, E. A.
  3. Cancer Research. 2004, SEP 15; 64(18): 6700-6706.
  1. 8.   Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP)
  2. Berman, D. M.; Shih, L. M.; Burke, L. A.; Veenstra, T. D.; Zhao, Y. M.; Conrads, T. P.; Kwon, S. W.; Hoang, V.; Yu, L. R.; Zhou, M.; Kurman, R. J.; Petricoin, E. F.; Liotta, L. A.
  3. Proteomics. 2004 4(3): 812-818.
  1. 9.   Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses
  2. Gerschenson, M.; Paik, C. Y.; Gaukler, E. L.; Diwan, B. A.; Poirier, M. C.
  3. Reproductive Toxicology. 2001 15(5): 525-531.
  1. 10.   Transplacental Cisplatin Exposure Induces Persistent Fetal Mitochondrial and Genomic Dna Damage in Patas Monkeys
  2. Giurgiovich, A. J.; Anderson, L. M.; Jones, A. B.; Dove, L. F.; Moskal, T. J.; Rice, J. M.; Olivero, O. A.; Poirier, M. C.
  3. Reproductive Toxicology. 1997 11(1): 95-100.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel